Investor FAQs

 

The Zosano Pharma ticker is ZSAN and it is traded on the NASDAQ Capital Market.

Zosano Pharma’s IPO was on January 27, 2015.

The underwriters for the IPO were Ladenburg Thalmann and Roth Capital Partners.

You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.

You can view our management team by visiting the Management section of our Investor Relations website.

Zosano Pharma’s fiscal year ends on December 31st

Marcum LLP

Zosano Pharma does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.

Computershare

Computershare Investor Centre www.computershare.com/investor

Email web.queries@computershare.com

Telephone inquiries
1-877-373-6374

Written requests Computershare P.O. Box 30170
College  Station, TX 77842-3170

Please contact Computershare Investor Centre @web.queries@computershare.com, or call 1-877-373-6374.

Zosano Pharma does not currently have a direct stock purchase plan.

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.

You can contact Zosano Pharma’s Investor Relations via email at: jjones@bplifescience.com

In addition, you can reach Investor Relations by calling 415-375-3340 x 5.

Please submit your question using the form below.

* Indicates required field